Search - tctmd.com

Displaying 21 - 30 of 30

Sort: Relevancy | Date

Presentation THT 2024

Update on Baroreceptor Activation Therapy

Presenter: Michael R. Zile

March 05, 2024

Presentation THT 2024

Relationship Between Remote, Ambulatory Pulmonary Artery Pressures and All-Cause Mortality in Patients with Chronic Heart Failure

Presenter: Michael R. Zile

March 05, 2024

News Conference News THT 2024

Debating the Role of T-TEER in the Sickest Patients

Michael O'Riordan

March 05, 2024

Presentation THT 2024

FDA-Approved But Less Frequently Used Device Therapies to Treat HFrEF: Challenges and Opportunities

Presenter: Michael R. Zile

March 04, 2024

Presentation THT 2023

Impact of the V-Wave® Ventura® Interatrial Shunt Device on Right and Left Ventricular Structure and Function: Complete 12-Month Results of the RELIEVE-HF Roll-in Cohort

Presenter: Michael Pfeiffer

March 21, 2023

Presentation THT 2023

Baroreflex Activation Therapy (BAT) in Patients With Heart Failure and a Reduced Ejection Fraction (BeAT-HF): Long-Term Outcomes

Presenter: Michael Zile

March 21, 2023

$Hierarchical composite endpoints for heart failure trials - answering the question: What fraction of the composite endpoint is due to cardiovascular mortality, hospitalization, or quality of life?$

Presentation THT 2023

Hierarchical composite endpoints for heart failure trials - answering the question: What fraction of the composite endpoint is due to cardiovascular mortality, hospitalization, or quality of life?

Presenter: Michael Sutherland

March 21, 2023

Presentation THT 2023

Cardiac Conditioning Induction by Paced Simulation of Exercise Heart Rate

Presenter: Michael Sauer

March 21, 2023

News Conference News THT 2023

TEER or VAD/Transplant in the Advanced HF Patient With MR?

Shelley Wood

March 20, 2023

Presentation THT 2022

Snare-Assisted Late Repositioning of Transcatheter Aortic Valve and Management of Ensuing Hemodynamic Sequelae

Presenter: Michael Vu

February 02, 2022

Advertisement

Update on Baroreceptor Activation Therapy

Relationship Between Remote, Ambulatory Pulmonary Artery Pressures and All-Cause Mortality in Patients with Chronic Heart Failure

Debating the Role of T-TEER in the Sickest Patients

FDA-Approved But Less Frequently Used Device Therapies to Treat HFrEF: Challenges and Opportunities

Impact of the V-Wave® Ventura® Interatrial Shunt Device on Right and Left Ventricular Structure and Function: Complete 12-Month Results of the RELIEVE-HF Roll-in Cohort

Baroreflex Activation Therapy (BAT) in Patients With Heart Failure and a Reduced Ejection Fraction (BeAT-HF): Long-Term Outcomes

Hierarchical composite endpoints for heart failure trials - answering the question: What fraction of the composite endpoint is due to cardiovascular mortality, hospitalization, or quality of life?

Cardiac Conditioning Induction by Paced Simulation of Exercise Heart Rate

TEER or VAD/Transplant in the Advanced HF Patient With MR?

Snare-Assisted Late Repositioning of Transcatheter Aortic Valve and Management of Ensuing Hemodynamic Sequelae

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content